Renan Vieira de Brito

Dr. Renan Vieira de Brito

Independent Researcher, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Renan Vieira de BritoRenan Vieira de Brito
Renan Vieira de Brito
MMMarília Wellichan Mancini
Marília Wellichan Mancini
MPMarcel Neves Palumbo
Marcel Neves Palumbo
LMLuis Henrique Oliveira de Moraes
Luis Henrique Oliveira de Moraes
GRGerson Jhonatan Rodrigues
Gerson Jhonatan Rodrigues
MPMarcos Paiva
Marcos Paiva
Cisplatin is one of the most widely used anticancer drugs in the treatment of various types of solid human cancers, as well as germ cell tumors, sarcomas, and lymphomas. Strong evidence from research has demonstrated higher efficacy of a combination of cisplatin and derivatives, together with hyperthermia and light, in overcoming drug resistance and improving tumoricidal efficacy. It is well known that the antioncogenic potential of CDDP is markedly enhanced by hyperthermia compared to drug treatment alone. However, more recently, accelerators of high energy particles, such as synchrotrons, have been used to produce powerful and monochromatizable radiation to induce an Auger electron cascade in cis-platinum molecules. This is the concept that makes photoactivation of cis-platinum theoretically possible. Both heat and light increase cisplatin anticancer activity via multiple mechanisms, generating DNA lesions by interacting with purine bases in DNA followed by activation of several signal transduction pathways which finally lead to apoptosis. For the past twenty-seven years, our group has developed infrared photo-thermal activation of cisplatin for cancer treatment from bench to bedside. The future development of photoactivatable prodrugs of platinum-based agents injected intratumorally will increase selectivity, lower toxicity and increase efficacy of this important class of antitumor drugs, particularly when treating tumors accessible to laser-based fiber-optic devices, as in head and neck cancer. In this article, the mechanistic rationale of combined intratumor injections of cisplatin and laser-induced thermal therapy (CDDP–LITT) and the clinical application of such minimally invasive treatment for cancer are reviewed.

23 September 2026 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
TMThomas Peter Maahs
Thomas Peter Maahs
MFMaurício Fontoura Ferrão
Maurício Fontoura Ferrão
NBNathália Perusso Becker
Nathália Perusso Becker
Renan Vieira de BritoRenan Vieira de Brito
Renan Vieira de Brito
CCCarlos Takahiro Chone
Carlos Takahiro Chone
GMGerson Schulz Maahs
Gerson Schulz Maahs

5 February 2025 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
FNFrancisco Campelo da Fonseca Neto
Francisco Campelo da Fonseca Neto
Renan Vieira de BritoRenan Vieira de Brito
Renan Vieira de Brito
EMEder Barbosa Muranaka
Eder Barbosa Muranaka
ACArthur Menino Castilho
Arthur Menino Castilho